| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,734 |
13,790 |
$2.34M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,701 |
13,881 |
$1.98M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
8,481 |
7,849 |
$1.80M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,203 |
1,964 |
$138K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
30,914 |
25,072 |
$133K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,459 |
1,980 |
$131K |
| 80053 |
Comprehensive metabolic panel |
21,305 |
17,800 |
$127K |
| 81513 |
|
830 |
750 |
$91K |
| 71045 |
Radiologic examination, chest; single view |
685 |
582 |
$87K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,482 |
4,998 |
$65K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,751 |
3,895 |
$60K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,043 |
1,777 |
$58K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,043 |
1,777 |
$58K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
662 |
223 |
$57K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,459 |
2,270 |
$56K |
| 71046 |
Radiologic examination, chest; 2 views |
569 |
468 |
$52K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,985 |
1,804 |
$51K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,564 |
2,309 |
$50K |
| 36415 |
Collection of venous blood by venipuncture |
28,922 |
20,299 |
$46K |
| 80061 |
Lipid panel |
4,774 |
4,397 |
$45K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,430 |
1,252 |
$42K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,627 |
1,277 |
$42K |
| 62323 |
|
34 |
27 |
$37K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
174 |
159 |
$28K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
264 |
243 |
$27K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,580 |
3,282 |
$24K |
| 87481 |
|
863 |
777 |
$23K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
78 |
66 |
$21K |
| 82607 |
|
1,627 |
1,503 |
$19K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
45 |
40 |
$17K |
| 86780 |
|
1,583 |
1,351 |
$16K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
238 |
210 |
$16K |
| 87563 |
|
556 |
447 |
$15K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
133 |
117 |
$11K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
138 |
72 |
$9K |
| 83550 |
|
1,047 |
960 |
$8K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
62 |
50 |
$7K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
597 |
543 |
$7K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
29 |
24 |
$6K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
139 |
110 |
$6K |
| 83540 |
|
1,047 |
960 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,230 |
1,479 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
925 |
759 |
$5K |
| 83735 |
|
925 |
858 |
$5K |
| E0603 |
Breast pump, electric (ac and/or dc), any type |
29 |
24 |
$5K |
| 82746 |
|
335 |
320 |
$4K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
17 |
12 |
$4K |
| 80047 |
|
421 |
349 |
$3K |
| 85027 |
|
1,073 |
832 |
$3K |
| 84484 |
|
459 |
365 |
$3K |
| 87634 |
|
65 |
57 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
49 |
41 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
149 |
116 |
$3K |
| 84702 |
|
316 |
233 |
$3K |
| 84439 |
|
342 |
321 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
12 |
$2K |
| 82728 |
|
212 |
185 |
$2K |
| 81001 |
|
1,528 |
1,271 |
$2K |
| 87070 |
|
369 |
350 |
$2K |
| 59025 |
Fetal non-stress test |
16 |
14 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
834 |
654 |
$2K |
| 84144 |
|
119 |
105 |
$2K |
| 86803 |
|
204 |
152 |
$2K |
| 84481 |
|
124 |
111 |
$2K |
| 87510 |
|
191 |
166 |
$2K |
| 87660 |
|
191 |
166 |
$2K |
| 87480 |
|
191 |
166 |
$2K |
| 86706 |
|
191 |
150 |
$1K |
| 86850 |
|
371 |
299 |
$1K |
| 86696 |
|
94 |
76 |
$1K |
| 83690 |
|
529 |
419 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
29 |
26 |
$1K |
| 81003 |
|
646 |
552 |
$995.18 |
| 86762 |
|
88 |
67 |
$935.37 |
| 87340 |
|
136 |
102 |
$885.14 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
100 |
38 |
$757.40 |
| 86695 |
|
63 |
51 |
$593.55 |
| 86376 |
|
48 |
41 |
$582.88 |
| 86901 |
|
266 |
220 |
$500.08 |
| 86900 |
|
266 |
220 |
$500.08 |
| 81025 |
|
133 |
104 |
$484.64 |
| 96132 |
|
17 |
12 |
$414.12 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$343.83 |
| 83021 |
|
19 |
13 |
$307.02 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
13 |
13 |
$279.67 |
| 82950 |
|
72 |
65 |
$267.71 |
| 80164 |
|
26 |
19 |
$178.42 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,410 |
1,095 |
$173.77 |
| 82105 |
|
12 |
12 |
$150.93 |
| 84703 |
|
29 |
27 |
$143.34 |
| 82977 |
|
19 |
14 |
$86.40 |
| 82150 |
|
19 |
14 |
$77.76 |
| 84460 |
|
19 |
14 |
$63.60 |
| 84075 |
|
19 |
14 |
$62.16 |
| 84450 |
|
19 |
14 |
$62.16 |
| 82247 |
|
19 |
14 |
$60.24 |
| 82040 |
|
19 |
14 |
$59.40 |
| 84155 |
|
19 |
14 |
$44.04 |
| 82565 |
|
12 |
12 |
$35.84 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
392 |
274 |
$3.65 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
106 |
77 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
19 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
175 |
93 |
$0.00 |
| 96139 |
|
17 |
12 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
18 |
12 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
49 |
26 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
22 |
13 |
$0.00 |
| 96138 |
|
17 |
12 |
$0.00 |
| 96133 |
|
17 |
12 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
524 |
353 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
561 |
225 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
145 |
110 |
$0.00 |